Allos Therapeutics (ALTH) Tops Q4 EPS by 6c
Tweet
Share
E-mailGet Alerts ALTH Hot Sheet
Price: $1.84 --0%
Financial Fact:
Net income (loss): -11.32M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Net income (loss): -11.32M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Allos Therapeutics (NASDAQ: ALTH) reported Q4 EPS of ($0.01), $0.06 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $15.4 million versus the consensus estimate of $15.94 million.
For earnings history and earnings-related data on Allos Therapeutics (ALTH) click here.
For earnings history and earnings-related data on Allos Therapeutics (ALTH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- DA Davidson Reiterates Buy Rating on Walmart (WMT) Ahead of Earnings
- Enovix Corporation (ENVX) PT Lowered to $5 at BofA Securities
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
